Recurrent pregnancy loss: Evaluation and treatment

Obstetrics and Gynecology Clinics of North America

Volumn 42, Issue 1, 2015, Pages 117-134

  Shahine, Lora ^a,b   Lathi, Ruth ^c  

^a Pacific NW Fertility and IVF Specialists ^*  (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Recurrent embryonic loss; Recurrent fetal loss; Recurrent miscarriage; Recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PROGESTERONE; THYROTROPIN; THYROXINE;

ANEUPLOIDY; ANTIPHOSPHOLIPID SYNDROME; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FERTILIZATION IN VITRO; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HYPERPROLACTINEMIA; INFECTION; LOW DRUG DOSE; MORBIDITY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RECURRENT PREGNANCY LOSS; REVIEW; SPONTANEOUS ABORTION; THROMBOPHILIA; THYROID FUNCTION; UTERUS MALFORMATION; ABORTION, HABITUAL; CHROMOSOME ABERRATION; COMPLICATION; EMBRYO DEATH; EMBRYOLOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GENETIC PREDISPOSITION; PATHOPHYSIOLOGY; PREGNANCY; PREVENTION AND CONTROL; UTERINE CERVICAL INCOMPETENCE;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATIONS; EMBRYO LOSS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; UTERINE CERVICAL INCOMPETENCE;

EID: 84922522317     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2014.10.002     Document Type: Review

References (126)

1. Practice Committee Opinion of the American Society of Reproductive Medicine Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012, 98:1103-1111.
2. Ansari A.H., Kirkpatrick B. Recurrent pregnancy loss. An update. JReprod Med 1998, 43:806-814.
3. Stirrat G.M. Recurrent miscarriage. Lancet 1990, 336:673-675.
4. Wilcox A.J., Weinberg C.R., O'Connor J.F., et al. Incidence of early loss of pregnancy. NEngl J Med 1988, 319:189-194.
5. Edmonds D.K., Lindsay K.S., Miller J.F., et al. Early embryonic mortality in women. Fertil Steril 1982, 38:447-453.
6. Jacobs P.S., Hassold T. Chromosomal abnormalities: origin and etiology in abortuses and live births. Human genetics 1987, 233-244. Springer-Verlag, Berlin. F. Vogel, K. Sperlin (Eds.).
7. Knudsen U.B., Hansen V., Juul S., et al. Prognosis of a new pregnancy following previous spontaneous abortions. Eur J Obstet Gynecol Reprod Biol 1991, 39:31-36.
8. Harger J.H., Archer D.F., Marchese S.G., et al. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 1983, 62:574-581.
9. Acien P., Acien M., Sanchez-Ferrer M. Complex malformations of the female genital tract. New types and revision of classification. Hum Reprod 2004, 19:2377-2384.
10. Stephenson M.D., Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 2007, 50:132-145.
11. Royal College of Obstetricians and Gynaecologists, Scientific Advisory Committee, Guideline No. 17. The investigation and treatment of couples with recurrent miscarriage. 2011. Available at:. Accessed March 22, 2012. http://www.rcoag.org.uk/womens-health/clinical-guidance/investigation-and-treatment-couples-recurrent-miscarriage-green-top-.
12. Stephenson M.D. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996, 66:24-29.
13. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two vs. three or more recurrent pregnancy losses. Fertil Steril 2010, 93:1234-1243.
14. Christiansen O.B., Nybo Andersen A.M., Bosch E., et al. Evidence-based investigations and treatment of recurrent pregnancy loss. Fertil Steril 2005, 83:821-839.
15. Rai R., Regan L. Recurrent miscarriage. Lancet 2006, 368:601-611.
16. Grimbizis G.F., Camus M., Tarlatzis B.C., et al. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001, 7:161-174.
17. Simpson J.L. Causes of fetal wastage. Clin Obstet Gynecol 2007, 50:10-30.
18. Pabuçcu R., Atay V., Orhon E., et al. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril 1997, 68:1141-1143.
19. Hall-Craggs M.A., Kirkham A., Creighton S.M. Renal and urological abnormalities occurring with Mullerian anomalies. JPediatr Urol 2013, 9:27-32.
20. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update if the classification criteria for definite antiphospholipid syndrome (APS). JThromb Haemost 2006, 4:295-306.
21. Committee on Practice Bulletins-Obstetrics, American College of Obstetricians and Gynecologists Practice bulletin No. 132: antiphospholipid syndrome. Obstet Gynecol 2012, 120:1514-1521.
22. Yetman D.L., Kutteh S.R. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996, 55:540-546.
23. Opartrny L., David M., Kahn S.R., et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a meta-analysis. JRheumatol 2006, 33:2214-2221.
24. Adler R.R., Ng A.K., Rote N.S. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995, 53:905-910.
25. Rote N.S., Lyden T.W., Vogt E., et al. Chapter 18: antiphospholipid antibodies and placental development. Immunobiology of reproduction 1994, 285-302. Springer-Verlaf, New York. J.S. Hunst (Ed.).
26. Katsuragawa H., Kanzaki H., Iniue T., et al. Monoclonal antibody against phosphatidylserine inhibits invitro human trophoblastic hormone production and invasion. Biol Reprod 1997, 56:50-58.
27. Di Simone N., Meroni P.L., de Papa N., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000, 43:140-150.
28. Rote N.S., Stetzer B. Autoimmune disease as a cause of reproductive failure. Clin Lab Med 2003, 23:265-293.
29. DiSimone N., Catellani R., Caliandro D., et al. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2001, 65:1766-1770.
30. Vogt E., Ng A.K., Rote N.S. Antiphosphatidylserine antibody removes annexin V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 1997, 177:964-972.
31. Rand J.H. The pathogenic role of annexin-V in the antiphospholipid syndrome. Curr Rheumatol Rep 2000, 2:246-251.
32. Rand J.H. The antiphospholipid syndrome. Annu Rev Med 2003, 54:409-424.
33. Giardi G., Bulla R., Salmon J.E., et al. The complement system in the pathophysiology of pregnancy. Mol Immunol 2006, 43:68-77.
34. Branch D.W., Andres R., Difre K.B., et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989, 73:541-545.
35. Sletnes K.E., Wisloff F., Moe N., et al. Antiphospholipid antibodies in preeclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992, 71:112-117.
36. Yamamoto T., Yoshimura S., Geshi Y., et al. Measurement of antiphospholipid antibody of ELISA using purified bet 2-glycoprotein I in preeclampsia. Clin Exp Immunol 1993, 94:196-200.
37. Dekker G.A., de Vries J.I., Doelitzsch P.M., et al. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol 1995, 173:1042-1048.
38. Moodley J., Bhoota V., Duursma J., et al. The association of antiphospholipid antibodies with severe early onset pre-eclampsia. SAfr Med J 1995, 85:105-107.
39. Allen J.Y., Tapia-Santiago C., Kutteh W.H. Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol 1996, 36:81-85.
40. Yamamoto T., Takahashi T., Geshi T., et al. Anti-phospholipid antibodies in preeclampsia and their binding ability for placental villous lipid fractions. JObstet Gynaecol Res 1996, 22:275-283.
41. Van Pampus M.G., Dekker G.A., Wolf H., et al. High prevalence of hemostatic abnormalities in women with a history of server preeclampsia. Am J Obstet Gynecol 1999, 180:1146-1150.
42. Branch D.W., Silver R., Pierangeli S., et al. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997, 90:642-644.
43. de Jong P.G., Kaandorp S., Di Nisio M., et al. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev 2014, (7). CD004734.
44. Kaandorp S.P., Goddijn M., van der Post J.A., et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. NEngl J Med 2010, 362:1586-1596.
45. Empson M., Lassere M., Craig J.C., et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002, 99:135-144.
46. Empson M., Lassere M., Craig J., et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005, (2). CD002859.
47. Ziakis P.D., Pavlou M., Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss. A systematic review and meta-analysis. Obstet Gynecol 2010, 115:1256-1262.
48. Laskin C.A., Bombardier C., Hannah M.E., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. NEngl J Med 1997, 337:148-153.
49. De Groot L., Abalovich M., Alexander E.K., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. JClin Endocrinol Metab 2012, 97:2543-2565.
50. Casey B.M., Dashe J.S., Wells C.E., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005, 105:239-245.
51. Glinoer D., Soto M.F., Bourdoux P., et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. JClin Endocrinol Metab 1991, 73:421-427.
52. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. NEngl J Med 1999, 341:549-555.
53. Leung A.S., Millar L.K., Koonings P.P., et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993, 81:349-353.
54. Man E.B., Brown J.F., Serunian S.A. Maternal hypothyroxinemia: psychoneurological deficits of progeny. Ann Clin Lab Sci 1991, 21:227-239.
55. Ablaovich M., Guiterrez S., Alcaraz G., et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002, 12:63-68.
56. De Vivo A., Mancuso A., Giacobbe A., et al. Thyroid function in women found to have early pregnancy loss. Thyroid 2010, 20:633-637.
57. De Carolis C., Greco E., Guarino M.D., et al. Antithyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol 2004, 52:263-266.
58. Stagnaro-Green A., Roman S.H., Cobin R.H., et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990, 264:1422-1425.
59. Iravani A.T., Saeedi M.M., Pakravesh J., et al. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 2008, 14:458-464.
60. Negro R., Mangieri T., Coppola L., et al. Levothyroxine treatment in thyroid peroxidase antibody positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 2005, 20:1529-1533.
61. Millar L.K., Wing D.A., Leung A.S., et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994, 84:946-949.
62. Negro R., Schwartz A., Gismondi R., et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. JClin Endocrinol Metab 2010, 95:E44-E48.
63. Allan W.C., Haddow J.E., Palomaki G.E., et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. JMed Screen 2000, 7:127-130.
64. Vaidya B., Antony S., Bilous M., et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?. JClin Endocrinol Metab 2007, 92:203-207.
65. Tan T.O., Cheng Y.W., Caughey A.B. Are women who are treated for hypothyroidism at risk of pregnancy complications?. Am J Obstet Gynecol 2006, 194:e1-e3.
66. Männistö T., Vääräsmäki M., Pouta A., et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. JClin Endocrinol Metab 2010, 95:1084-1094.
67. Jovanovic L., Knopp R.H., Kim H., et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes. Diabetes Care 2005, 28:1113-1117.
68. Greene M.F., Hare J.W., Cloherty J.P., et al. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989, 39:225-231.
69. Miller E., Hare J.W., Cloherty J.P., et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. NEngl J Med 1981, 304:1331-1334.
70. Ylinen K., Aula P., Stenman U.H., et al. Risk of minor and major fetal malformations in diabetics with high haemoglobin A1C values in early pregnancy. Br Med J (Clin Res Ed) 1984, 289:345-346.
71. Mills J.L., Simpson J.L., Driscoll S.G., et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. NEngl J Med 1988, 319:1617-1623.
72. Hirahara F., Andoh N., Sawai K., et al. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998, 70:246-252.
73. Practice Committee of the American Society for Reproductive Medicine The clinical relevance of luteal phase deficiency: a committee opinion. Fertil Steril 2012, 98:1112-1117.
74. Murray M.J., Meyer W.R., Zaino R.J., et al. Acritical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril 2004, 81:1333-1343.
75. Coutifaris C., Myers E.R., Guzick D.S., et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004, 82:1264-1272.
76. Ogasawara M., Kajiura S., Katano K., et al. Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies?. Fertil Steril 1997, 68:806-809.
77. Haas D.M., Ramsey P.S. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2008, (2). CD003511.
78. Goldstein P., Berrier J., Rosen S., et al. Ameta-analysis of randomized controlled trials of progestational agents in pregnancy. Br J Obstet Gynaecol 1989, 96:265-274.
79. Oates-Whitehead R.M., Haas D.M., Carrier J.A. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2003, (4). CD003511.
80. Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet Gynaecol 1989, 96:275-280.
81. Dizon-Townson D., Miller C., Sibai B., et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005, 106:517-524.
82. Silver R.M., Zhao Y., Spong C.Y., et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010, 115:14-20.
83. De Jong P.G., Goddijin M., Middwldorp S. Testing for inherited thrombophilia in recurrent miscarriage. Semin Reprod Med 2011, 29:540-545.
84. Penta M., Lukic A., Conte M.P., et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol 2003, 26:329-337.
85. American College of Obstetricians and Gynecologists ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces technical bulletin number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002, 78:179-190.
86. Plouffe L., White E.W., Tho S.P., et al. Etiologic factors of recurrent abortion and subsequent reproductive performance of couples: have we made any progress in the past 10 years?. Am J Obstet Gynecol 1992, 167:313-320. [discussion: 320-1].
87. Gopalkrishnan K., Padwal V., Meherji P.K., et al. Poor quality of sperm as it affects repeated early pregnancy loss. Arch Androl 2000, 45:111-117.
88. Carrell D.T., Wilcox A.L., Lowy L., et al. Elevated sperm chromosome aneuploidy and apoptosis in patients with unexplained recurrent pregnancy loss. Obstet Gynecol 2003, 101:1229-1235.
89. Hill J.A., Abbott A.F., Politch J.A. Sperm morphology and recurrent abortions. Fertil Steril 1994, 61:776-778.
90. Carrell D.T., Liu L., Peterson C.M., et al. Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl 2003, 49:49-55.
91. Mansour Ghanaie M., Asgari S.A., Dadrass N., et al. Effects of varicocele repair on spontaneous first trimester miscarriage: a randomized clinical trial. Urol J 2012, 9:505-513.
92. Porter T.F., LaCoursiere Y., Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006, (2). CD000112.
93. Stephenson M.D., Dreher K., Houlihan E., et al. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998, 39:82-88.
94. Hutton B., Sharma R., Fergusson D., et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2007, 114:134-142.
95. Lindbohm M.L., Sallmen M., Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002, 28(Suppl 2):84-96.
96. Ness R.B., Grisso J.A., Hirshinger N., et al. Cocaine and tobacco use and the risk of spontaneous abortion. NEngl J Med 1999, 340:333-339.
97. Kesmodel U., Wisborg K., Olsen S.F., et al. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol 2002, 37:87-92.
98. Boots S., Stephensen M.D. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med 2011, 29:507-513.
99. Metwally M., Saravelos S.H., Ledger W.L., et al. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 2010, 94:290-295.
100. Boots C.E., Bernardi L.A., Stephenson M.D. Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril 2014, 102:455-459.
101. Stray-Pedersen B., Stray-Pedersen S. Recurrent abortion: the role of psychotherapy. Early pregnancy loss: mechanisms and treatment 1988, 433-440. Springer-Verlag, New York. R.W. Beard, F. Ship (Eds.).
102. Stray-Pedersen B., Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984, 148:140-146.
103. Stephenson M.D., Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod 2006, 21:1076-1082.
104. Fischer J., Colls P., Escudero T., et al. Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses. Fertil Steril 2010, 94:283-289.
105. Lim C.K., Jun J.H., Min D.M., et al. Efficacy and clinical outcome of preimplantation genetic diagnosis using FISH for couples of reciprocal and robertsonian translocations: the Korean experience. Prenat Diagn 2004, 24:556-561.
106. Otani T., Roche M., Mizuike M., et al. Preimplantation genetic diagnosis significantly improves the pregnancy outcome of translocation carriers with a history of recurrent miscarriage and unsuccessful pregnancies. Reprod Biomed Online 2006, 13:869-874.
107. Scriven P.N., Flinter F.A., Khalaf Y., et al. Benefits and drawbacks of preimplantation genetic diagnosis (PGD) for reciprocal translocations: lessons from a prospective cohort study. Eur J Hum Genet 2013, 21:1035-1041.
108. Daniely M., Avrium-Goldring A., Barkai G., et al. Detection of chromosomal aberration in fetuses arising from recurrent spontaneous abortion by comparative genomic hybridization. Hum Reprod 1998, 13:805-809.
109. Ogasawara M., Aoki K., Okada S., et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000, 73:300-304.
110. Carp H., Toder V., Avirum A., et al. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001, 75:678-682.
111. Fritz B., Hallermann C., Olert J., et al. Cytogenetic analyses of culture failures by comparative genomic hybridisation (CGH)-Re-evaluation of chromosome aberration rates in early spontaneous abortions. Eur J Hum Genet 2001, 9:539-547.
112. Sullivan A.E., Silver R.M., La Coursiere D.Y., et al. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 2004, 104:784-788.
113. Stephenson M.D., Awartani K.A., Robinson W.P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 2002, 17:446-451.
114. McFadyen I.R. Early fetal loss. Fetal medicine 1989, 26-43. Blackwell Scientific, Oxford (United Kingdom). C. Rodek (Ed.).
115. Hassold T., Chiu D. Maternal age specific rated of numerical chromosome abnormalities with special reference to trisomy. Hum Genet 1985, 70:11-17.
116. Marquard K., Westphal L., Milki A., et al. Etiology of recurrent pregnancy loss in women over the age of 35. Fertil Steril 2010, 94:1473-1477.
117. Mantzouratou A., Mania A., Fragouli E., et al. Variable aneuploidy mechanism in embryos from couples with poor reproductive histories undergoing preimplantation genetic screening. Hum Reprod 2007, 22:1844-1853.
118. Kiss A., Rosa R.F., Dibi R.P. Chromosomal abnormalities in couples with history of recurrent abortion. Rev Bras Ginecol Obstet 2009, 31:68-74.
119. Pellicer A., Rubio C., Vidal F., et al. Invitro fertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation embryos. Fertil Steril 1999, 71:1033-1039.
120. Simon C., Rubio C., Vidal F., et al. Increased chromosome abnormalities in human preimplantation embryos after in-vitro fertilization in patients with recurrent miscarriage. Reprod Fertil Dev 1998, 10:87-92.
121. Vidal F., Gimenez C., Rubio C., et al. FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. JAssist Reprod Genet 1998, 15:310-313.
122. Rubio C., Simon C., Vidal F., et al. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod 2003, 18:182-188.
123. Munne S., Chen S., Fischer J., et al. Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril 2005, 84:331-335.
124. Brigham S.A., Conlon C., Farquharson R.G. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999, 14(11):2868-2871.
125. Hodes-Wertz B., Grio J., Ghadir S., et al. Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertil Steril 2012, 98:675-680.
126. Platteau P., Staessen C., Michiels A., et al. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril 2005, 83:393-397. [quiz: 525-6].